Research
Huanglian
2 peer-reviewed studies curated from PubMed and Semantic Scholar.
0
Meta-analyses
0
Systematic reviews
1
RCTs
1
Other studies
RCTs (50%)
Studies
Sorted by quality and recency
2023·Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·Jiang Li, F U Qiang, Wang Shidong, et al
Effects of Shenlian formula on microbiota and inflammatory cytokines in adults with type 2 diabetes: a double-blind randomized clinical trial.
RCTn = 31Gut Health ↑Inflammation ↑Nutrition ↑
Double-blind, randomized clinical trial of Shenlian formula in 31 adults with type 2 diabetes mellitus. The formula improved postprandial blood glucose, insulin resistance, BMI, and CRP levels, and modulated gut microbiota by reducing species richness and increasing probiotics.
PubMedRead on PubMed
2023·Frontiers in endocrinology·Shuquan Lv, Zhongyong Zhang, Xiuhai Su, et al
Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
Animal studyGut Health ↑Inflammation ↓
The study investigated the effects of Qingrequzhuo capsule (QRQZ) on nonalcoholic steatohepatitis (NASH) in a mouse model induced by a methionine and choline deficient diet. QRQZ treatment reduced liver lipid accumulation and inflammation, modulated gut microbiota, enhanced gut tight junctions, and inhibited the TLR4/NF-kB signaling pathway.
PubMedRead on PubMed